The Cannigma

JUNE 30, 2021

In these three dozen states, from the West Coast to the Midwest to the South and the Northeast, patients use cannabis to treat countless medical conditions and everyday ailments. of patients reported chronic pain as their primary condition, while in Connecticut 70.4% of the patients identified as white, including 96% in Maine.

Chronic Pain 137

Chronic Pain Marijuana Conditions Patients 137

Cannabis Law Report

FEBRUARY 25, 2022

Medical cannabis producers in the state had requested tax refunds in 2014 and in 2018 but the state Taxation and Revenue Department had denied those claims. Ultra Health, one of the state’s largest medical cannabis producers, which had filed the original lawsuits, had not been charging patients taxes, and instead had been absorbing the taxes.

Programs 52

Programs Collective Data Patients 52

Cannabis Law Report

APRIL 12, 2019

A patient in Alberta spending $600 (~€397) per month on medical cannabis will pay 24.3% ($145.80) in tax. For most Canadian patients, including myself, this means 24.3% CFAMM’s goal is to support medical cannabis patients, improve their outcomes and enable them to obtain fair and safe access to their medication.

Access 45

Access Patients Marijuana Medicine 45

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. The governor also signed Senate Bill 1700 to protect the privacy of doctors recommending low-THC marijuana and their patients.

Law 126

Law Marijuana Patients Treatment 126

PrestoDoctor

SEPTEMBER 6, 2023

It has been a go-to option for healthcare professionals seeking to manage pain effectively for their patients. This has led many patients to explore cannabis as a potential substitute for prescription codeine. Additionally, common side effects such as drowsiness, constipation, and respiratory depression can be burdensome for patients.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Canna Care Docs

DECEMBER 16, 2020

It would feel like an out-of-body experience, except for one fact: your body is constantly reminding you of those symptoms you’ve been suffering from all this time, putting treatment on the back burner while you deal with life as we know it. Enough is enough. Nausea and vomiting. Multiple sclerosis.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

SpeedWeed

MARCH 6, 2021

Forcing patients to purchase more. Doing so, Pollara wrote, would effectively force a 50% to 150% tax on patients. It is also the one which produces the most and strongest medicinal effects for patients. Patients will feel the effects of THC caps almost immediately,” Pollara added. Here’s how Pollara explained it: .

THC 52

THC Patients Law Chronic Pain 52

MMJ Recs

FEBRUARY 8, 2021

Medical marijuana in New York has been legal since legislation for the Compassionate Care Act was passed in June of 2014. Medicaid, or other health insurances, do not cover the use of medical marijuana for any chronic illness, and thus, those looking to supplement their treatment with cannabis will have to pay out of pocket.

Legalization 52

Legalization Edibles Patients Treatment 52

Greencamp

APRIL 23, 2019

Canada is one of the countries with the highest numbers of MS patients. For patients who don’t respond well to conventional MS methods, cannabis treatment seems like a very reasonable choice. However, not all patients respond to these treatments well enough, and some don’t respond at all.

Research and Development 94

Research and Development Strains Patients Treatment 94

Cannabis Law Report

JULY 24, 2022

The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years [1]. The legal framework regarding the use of psychedelics in patients is very pragmatic in Switzerland and unique internationally. Daniel Haymann. Daniel Donauer.

Research and Development 52

Research and Development Legalization Treatment Patients 52

Cannabis Law Report

JUNE 1, 2021

As we prepare for a potential world-class launch of Vicineum, I strongly believe that these leaders will not only bring diverse and invaluable expertise to our team but will also drive the Company to continue executing our mission to save and improve the lives of patients with cancer.”. CAMBRIDGE, Mass.–(BUSINESS

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. These treatments can be prescribed only by specialist doctors in a limited number of circumstances where other medicines have failed. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

JANUARY 9, 2022

Since 2014 when sales began in Colorado and Washington, legalization policies have provided states a new revenue stream to bolster budgets and fund important services and programs. Washington’s voters also approved an adult-use measure in November 2012, and its first stores opened in July 2014. Here’s what they say. 46,104,922.

Collective 52

Collective Policy Retail Programs 52

Veriheal

JANUARY 5, 2022

Young and Joyce’s letter places a lot of importance on being able to benefit from the therapeutic properties of cannabis as well as being able to get better—and more—data. Young’s Trail of Cannabis Reform. The pair conclude their letter by stating: “We can appreciate when leaders come from different concerns and priorities.

Legislation 52

Legislation Cannabis Therapy Access 52

Cannabis Law Report

JUNE 7, 2021

Since 2014, when sales began in Colorado and Washington, legalization policies have provided states a new revenue stream to bolster budgets and fund important services and programs. Washington’s voters also approved an adult-use measure in November 2012, and its first stores opened in July 2014. Colorado (pop. 46,104,922. 104,759,961.

Marijuana 91

Marijuana Retail Collective Programs 91

Cannabis Info

MARCH 12, 2019

There is no data recorded on any federal database anywhere. Recently, it even led to the authorities shutting down the Cannabis Cup in Amsterdam in 2014. As written into law, currently a patient who receives even the most liberal prescription, will not be able to overdose on the same. . This includes opioids and cocaine.

Research and Development 45

Research and Development Concentrates Cannabinoids Cannabis 45

Healer

APRIL 5, 2021

While there’s substantial human research that pharmaceutical combinations of CBD and THC can reduce pain, at the present time there’s much less data on CBD or CBD-dominant hemp products used alone for pain, but there are several small studies that suggest effectiveness, often at higher doses, according to Dr. Sulak.

CBD 98

CBD Chronic Pain Oil Topical 98

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. “Patient referrals and training requests from our physician colleagues have increased by more than 500 per cent over the last year,” says Dr. .

Programs 108

Programs Research and Development Education Treatment 108

Healer

APRIL 5, 2021

While there’s substantial human research that pharmaceutical combinations of CBD and THC can reduce pain, at the present time there’s much less data on CBD or CBD-dominant hemp products used alone for pain, but there are several small studies that suggest effectiveness, often at higher doses, according to Dr. Sulak.

CBD 52

CBD Chronic Pain Oil Topical 52

Healer

APRIL 5, 2021

While there’s substantial human research that pharmaceutical combinations of CBD and THC can reduce pain, at the present time there’s much less data on CBD or CBD-dominant hemp products used alone for pain, but there are several small studies that suggest effectiveness, often at higher doses, according to Dr. Sulak.

CBD 52

CBD Chronic Pain Oil Topical 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. The states’ situation varies substantially.

Research and Development 52

Research and Development Medicine Access Media 52

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. “Patient referrals and training requests from our physician colleagues have increased by more than 500 per cent over the last year,” says Dr. .

Programs 40

Programs Research and Development Education Treatment 40

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Green Relief

MAY 13, 2018

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. Highlights: According to a U.S.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. Highlights: According to a U.S.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

The Cannigma

DECEMBER 8, 2021

To hear more of JM’s thoughts on the importance of small victories, how to build momentum, and patient rights, tune in today! It’s not with volumes of data, and facts and figures. And by 2014, I was a leader within Virginia NORML, and by 2015, I was executive director and I started working at NORML and –. Music by Desca.

Access 81

Access Policy Patients Cannabis 81

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. Consequently, they sorted the publications into three main groups: psychiatry, cancer treatment, and neurology.

Medicine 81

Medicine Research and Development Data Policy 81

Greenspoon Marder Cannabis Law Group Blog

JUNE 25, 2021

The Tax Court in Patients Mutual [15] Assistance Collective Coop. Moreover, as a result of the enactment of what is commonly referred to as the Tax Cuts and Jobs Act of 2017 (the “Act”), the treatment of income derived by foreign affiliates of U.S. 11] Patients Mutual Assistance Collective Coop. Instead, only the U.S.

Business 72

Business Cannabis Seed-To-Sale Law 72

MedicalJane

DECEMBER 13, 2017

Introduced in July 2014, New York’s medical marijuana program has been a work in progress from the get-go. The state recently announced an expansion to its program that is beginning to open the door to improved patient access. The struggle to connect with patients brought scrutiny from public officials, including state Sen.

Programs 49

Programs Patients Chronic Pain Marijuana 49

Cannabis Law Report

JULY 12, 2019

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

AUGUST 24, 2019

Patients, physicians, and the public all want to learn more about medical marijuana. Alaska voters legalized recreational marijuana in 2014. In addition to banking obstacles in the cannabis business, there is a long trail ahead before there is unfettered banking access for cannabis patients.

Banking 49

Banking Marijuana Media Patients 49

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Sessa is also the Chief Medical Officer of Awakn Life Sciences, and has been a part of scientific and clinical studies administering LSD, psilocybin, ketamine, MDMA and DMT to patients and volunteers. Brian Muraresku. and Canadian markets. In 2015, Cannabase.io Bia Labate.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

SpeedWeed

DECEMBER 28, 2018

In August, Constellation Brands (brewers of Corona beer) spent $4 billion to massively up their stake in Canopy Growth, which in 2014 became the first publicly traded cannabis company in North America, and now lists on both the New York Stock Exchange and the Toronto Stock Exchange. Bummer: Patients Are Still Struggling for Cannabis Access.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

SEPTEMBER 12, 2019

A 2017 law implementing the program called for 10 new licenses, then four additional licenses for every 100,000 patients. Despite the current legal confusion, Florida’s MMJ market has been growing at a gallop: The number of active patients has nearly tripled, from 56,537 as of Dec. 1, 2017, to 159,107 as of Dec. 381.986(8)(e).

Seed-To-Sale 65

Seed-To-Sale Supply Chain Business Programs 65

Cannabis Law Report

JULY 30, 2019

The informed patients, cannabis industry employees, and clinicians find it equally difficult to keep updated on Florida’s latest medical marijuana program news and changes. . In light of all this state cannabis information overload, what are some of the reasons a patient ultimately chooses a qualified personal cannabis physician? .

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

MARCH 2, 2020

After the thermal treatment, the green hardware is physically separated. For example a patient-safe, secure system of cannabis disposal could operate within Florida in the same manner as the plethora of statewide “no questions asked” needle disposal/exchange programs currently offered to the general public.

Vaping 59

Vaping Collective Research and Development Packaging 59

Cannabis Law Report

OCTOBER 17, 2019

Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. Another researcher, New Frontier Data, pegged the global value of legal and illicit cannabis together at $340 billion in 2018.

Law 40

Law Seed-To-Sale Hemp Recreational 40